Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease

Questions? Call 800-624-6242

About | Ordering | New

LoginRegister

| Items in cart [0]

PAPERBACK
price:$47.00
add to cart

Rights & Permissions

Free PDF Access

Free Resources

Related Titles

Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease (2010)
Board on Health Care Services (HCS)
Board on Health Sciences Policy (HSP)
Food and Nutrition Board (FNB)

Citation Manager Export the bibliographic data for this book in your chosen format
Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web.
Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book.
Reference Finder Paste in your own text to find books that relate to your topic.

Citation Manager

. "Front Matter." Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease. Washington, DC: The National Academies Press, 2010.

Please select a format:

Page
XX


E-mail Share on facebook Facebook Share on delicious Delicious Share on stumbleupon Stumble Share on twitter Twitter More Sharing ServicesMore

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.

Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease

Appendix A

Tables

A-1		Historical Review of the Biomarker–Surrogate Endpoint Literature with Special Reference to the Nomenclature, Initial Reports, Systems of Classification, and Statistical Methods Developed for Their Evaluation,		252
A-2		Continuation of Table A-1 for 2007–2009,		267

Appendix B

Boxes

B-1		Summary of Recommendations to Develop Biomarker-Based Tools for Cancer,		278
B-2		Summary of Recommendations for The Future of Drug Safety: Promoting and Protecting the Health of the Public,		279